BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹30 Cr | ₹26 Cr | ₹-0.16 Cr | ₹3.65 Cr |
What is the latest Cash Flow from Financing Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹-0.16 Cr |
| Mar2021 | ₹3.65 Cr |
How is Cash Flow from Financing Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 11.97 | |
| Mar2024 | ₹30 Cr | 18.58 | |
| Mar2023 | ₹26 Cr | Positive | |
| Mar2022 | ₹-0.16 Cr | Negative | |
| Mar2021 | ₹3.65 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹134.6 Cr | 0.9% | -8.9% | -65.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹261,044.0 Cr | 8.4% | -8.8% | -10.2% | Stock Analytics | |
| REDINGTON | ₹21,240.8 Cr | 8.4% | 1.2% | 17.9% | Stock Analytics | |
| MMTC | ₹9,763.5 Cr | 1.9% | -3.6% | -0.3% | Stock Analytics | |
| HONASA CONSUMER | ₹8,993.2 Cr | 1.5% | -5.1% | 10.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,878.4 Cr | 10.1% | -3.3% | 7.4% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 0.9% |
-8.9% |
-65.5% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses